KONSTANTINE DRAKONAKIS
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
THOMAS BROOKS,
PAMELA M BUNES,
PAMELA M. BUNES,
DON CRAWFORD,
GEORGE T. GILLIES,
A. REENST LESEMANN,
SRIJOY MAHAPATRA,
MARY LAKE POLAN,
COLIN M. ROLPH,
JONATHAN SACKIER,
GENE SANDERS,
RUSSELL E. TWEEDDALE,
DAN WAGNER
DIRECTOR
MICHAEL B ARONSON,
JEFFERY A. BAIRD,
RICHARD EMMITT,
CHARLES HART,
PAUL HERMES,
ROBERT S LANGER,
CATO LAURENCIN,
CATO T LAURENCIN,
SACHA LEVY,
DANE MILLER,
NICHOLAS PACHUDA,
JOSEPH W REILLY,
KEVIN ROCCO,
KEVIN A ROCCO,
KEVIN A. ROCCO,
LEVY SACHA,
RUSSELL E TWEEDDALE,
DANIEL WAGNER
DIRECTOR
LOUIS M ALPERN,
ANIL ASRANI,
ANIL W ASRANI,
JENS BIERTUMPEL,
LEONARD BORRMANN,
MICHELLE CARPENTER,
ALEXEY CHERNUSHKIN,
ROBERT J DEMPSEY,
THOMAS GADEK,
TOM GADEK,
LAURIE GORDON,
BRUCE KUPER,
BRUCE KUPPER,
BRUCE P. KUPPER,
GORDON LAURIE,
GORDON W LAURIE,
GORDON W. LAURIE,
MARK LOGAN,
MARK B LOGAN,
MARK B. LOGAN,
JOHN MOORE,
MARC ODRICH,
JAMES M RAMEY,
COLIN ROLPH,
COLIN M ROLPH,
COLIN M. ROLPH,
AMIR SHOJAEI,
AMIR W SHOJAEI,
MAC THOMPSON,
W. MCILWAINE THOMPSON, JR.,
WILLIAM MCILWAINE THOMPSON, JR.,
ALEXEY VINOGRADOV
DIRECTOR
MICHAEL B ARONSON,
JEFFERY A. BAIRD,
RICHARD EMMITT,
CHARLES HART,
PAUL HERMES,
ROBERT S LANGER,
CATO LAURENCIN,
CATO T LAURENCIN,
SACHA LEVY,
DANE MILLER,
NICHOLAS PACHUDA,
JOSEPH W REILLY,
KEVIN ROCCO,
KEVIN A ROCCO,
KEVIN A. ROCCO,
LEVY SACHA,
RUSSELL E TWEEDDALE,
DANIEL WAGNER
DIRECTOR
ALEXANDER ARKIN,
AARON BENT,
JEREMY T. BEZDEK,
BEDA BOLZENIUS,
JEFFREY CHAMBERLAIN,
KEDAR GUPTA,
JOSEPH KENNEDY,
EDWARD LIBBY,
EDWARD LIDDY,
MARK LITTLE,
BILL MCCULLEN,
WILLIAM MCCULLEN,
DAVID MICHAEL,
DAVID SELDIN,
ADAM SHARKAWY,
ASHWIN SHASHINDRANATH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity, Debt
2024-09-06
D/A
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2022-03-30
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2022-03-30
D/A
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2020-07-07
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Debt
2020-07-07
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2020-07-07
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2019-07-01
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2018-11-16
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2018-03-01
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2017-05-05
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
2017-01-18
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
2017-01-18
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2017-01-27
D
BIOTECHNOLOGY
NO REVENUES
Equity
2016-11-22
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity, Debt
2014-05-12
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2016-06-07
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2016-02-12
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2016-02-12
D/A
BIOTECHNOLOGY
NO REVENUES
Equity
2013-11-19
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity, Debt
2014-05-12
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Debt
2015-07-14
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2014-05-12
D/A
BIOTECHNOLOGY
NO REVENUES
Equity
2013-11-19
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2014-05-12
D
BIOTECHNOLOGY
NO REVENUES
Equity
2013-11-19
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity, Debt
2011-12-23
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-11-16
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity, Debt
2011-12-23
D
OTHER
DECLINE TO DISCLOSE
Equity
2010-10-14
D/A
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Debt
2009-03-11
